HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Abstract Text:

Charles C Maponga,Qing Ma,Judianne C Slish,Gene D Morse,

The use of potent antiretroviral drugs has led to successful treatment of HIV infection in most high-income countries. However, therapy remains largely unaffordable to the resource-limited world, particularly to countries in sub-Saharan Africa. The disparity and subsequent disease burden are devastating to the poorly resourced countries, hence creating a greater demand for international collaboration. This review outlines key examples of emerging HIV pharmacotherapy issues, challenges, and priorities within resource-limited settings in order to lay groundwork for potential enchancement of international research collaboration efforts. The prevalence and distribution patterns of HIV infection and sociocultural factors found in sub-Saharan African settings are discussed. Challenges include drug financing, drug distribution infrastructure, and government commitment to responding to the HIV pandemic. Priorities include prevention of HIV transmission, management of pediatric patients, availability of affordable medicines, and addressing concerns over the quality of medicines. The potential for the effective international collaboration is enhanced when expertise and resources from the developed world are combined with an understanding of the unique priorities of resource-limited settings.

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Publishing Authors By Initials

CC Maponga,Q Ma,JC Slish,GD Morse,

For similar investigative techniques: epidemiologic methods: data collection: vital statistics: morbidity: prevalence research abstracts see: investigative techniques: epidemiologic methods: data collection: vital statistics: morbidity: prevalence research

PUBMED ID PMID:

MEDLINE DATE:

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Journal Published:

PUBLICATION TYPE: Review

Journal: Topics in HIV medicine : a publication of the Inte

VOLUME: 15

Page Numbers: 104-10

Journal Abbreviation:

ISSN: 1542-8826

DAY: 3

MONTH: 12

YEAR: 2007

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Information

Number of References: 41

LANGUAGE: eng

NlmUniqueID: 100954650

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Keywords Mesh Terms:

KEYWORDS: Prevalence

MESH TERMS: prevention & control

Chemical & Substance for Abstract: HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries. Information

Substance Name: Anti-HIV Agents

Registry Number: 0

Grant and Affiliation Information for HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.

AFFILIATION: University of Zimbabwe College of Health Science, Avondale, Harare, Zimbabwe. cmaponga@medsch.uz.ac.zw

Country: United States

AGENCY: United States NIDA

GRANT: DA015024

ACRONYM: DA

MEDLINETA: Top HIV Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries Related Publications

• A dinoflagellate AAA family member rescues a conditional yeast G1/S phase cyclin mutant through increased CLB5 accumulation.
• Advances in pharmacogenomics of antiretrovirals: an update.
• Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells.
• Assessing the impact of substance use and hepatitis coinfection on atazanavir and lopinavir trough concentrations in HIV-infected patients during therapeutic drug monitoring.
• Bone morphogenetic protein receptor 2 mutations in pulmonary hypertension.
• Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
• Compartmental pharmacokinetic analysis of oral amprenavir with secondary peaks.
• Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry.
• Direct selection of RNA beacon aptamers.
• Drug interactions between proton pump inhibitors and antiretroviral drugs.
• Duplicate publication.
• Effects of pyriproxyfen on California red scale (Hemiptera: Diaspididae) development and reproduction.
• Functional deficiency in IL-7 caused by an N-ethyl-N-nitrosourea-induced point mutation.
• Genome-wide analysis of transcriptional dependence and probable target sites for Abf1 and Rap1 in Saccharomyces cerevisiae.
• Global infectious disease surveillance and health intelligence.
• Global preparedness for public health emergencies.
• HIV pharmacotherapy issues, challenges, and priorities in sub-Saharan African countries.
• Hierarchical assembly of the siliceous skeletal lattice of the hexactinellid sponge Euplectella aspergillum.
• High resolution Fourier-domain optical coherence tomography of retinal angiomatous proliferation.
• Integration of atazanavir into an existing liquid chromatography UV method for protease inhibitors: validation and application.
• Multidrug resistance 1 polymorphisms and trough concentrations of atazanavir and lopinavir in patients with HIV.
• Pandemic influenza: studying the lessons of history.
• Rotationally resolved spectroscopy of jet-cooled NbMo.
• Simulations of dynamics and viscoelasticity in highly entangled solutions of semiflexible rods.
• Technology evaluation: BLP-25, Biomira Inc.
• The US pandemic influenza implementation plan at six months.
• Toxicity of systemic neonicotinoid insecticides to avocado thrips in nursery avocado trees.
• Transcription factor access to promoter elements.
• Use of the finite element method to assess impact of current on forearm and wrist during an electrical accident.
• Wide dynamic range germanium detector for perturbation crystallography.